🌶️Pepperpedia
Community(soon)

IP3-DAG Signaling

From Pepperpedia, the free peptide encyclopedia
IP3-DAG Signaling
Properties
CategoryMechanisms
Also known asphosphoinositide signaling, PIP2 signaling, PLC pathway
Last updated2026-04-14
Reading time3 min read
Tags
mechanismsignalingsecond-messenger

Overview

The IP3-DAG signaling system is the pathway through which many hormones, neurotransmitters, and growth factors mobilize intracellular calcium and activate protein kinase C (PKC). The axis is initiated when phospholipase C (PLC) cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) in the plasma membrane into two second messengers: inositol 1,4,5-trisphosphate (IP3), which diffuses into the cytoplasm, and diacylglycerol (DAG), which remains in the membrane.

IP3 binds its receptor (IP3R) on the endoplasmic reticulum, opening a large-conductance calcium channel and releasing calcium from intracellular stores. DAG remains in the membrane and, together with the released calcium, recruits and activates conventional PKC isoforms; the DAG-sensitive but calcium-insensitive novel PKCs respond to DAG alone. Together these two arms produce coordinated short-term and long-term responses.

The IP3-DAG system is engaged by Gq-coupled GPCRs (through PLC-beta), by receptor tyrosine kinases (through PLC-gamma), and by several other upstream activators. It is central to smooth muscle contraction, secretion, immune cell activation, platelet aggregation, and many developmental processes.

Mechanism / Process

  1. Receptor activation. A Gq-coupled GPCR or RTK is activated by ligand.

  2. PLC activation. Galpha-q directly activates PLC-beta isoforms; RTKs recruit and activate PLC-gamma isoforms through SH2 domain interactions.

  3. PIP2 cleavage. PLC cleaves PIP2 into IP3 and DAG. A small pool of PIP2 thus generates potent bioactive messengers.

  4. IP3 action. IP3 diffuses to IP3 receptors on the ER, triggering calcium release. The local calcium rise is often shaped into waves and oscillations.

  5. Calcium wave propagation. Released calcium sensitizes neighboring IP3Rs (calcium-induced calcium release), spreading the signal across the cell.

  6. DAG action. DAG recruits conventional PKCs (alpha, beta, gamma) to the membrane, where they are activated by the coincident presence of calcium; novel PKCs (delta, epsilon, eta, theta) are activated by DAG alone.

  7. PKC phosphorylates substrates. Targets include myosin light chain kinase, ion channels, receptors (contributing to desensitization), and numerous transcriptional and metabolic regulators.

  8. Termination. IP3 is metabolized by kinases and phosphatases; DAG is phosphorylated by DAG kinases to phosphatidic acid or hydrolyzed by lipases. Calcium is pumped back into the ER by SERCA. PIP2 is resynthesized from PI in the membrane.

Key Players / Molecular Components

  • Phospholipase C isoforms. PLC-beta1-4 (Gq-regulated), PLC-gamma1-2 (RTK-regulated), PLC-delta, PLC-epsilon, PLC-zeta.
  • PIP2. Membrane lipid substrate and independent signaling molecule.
  • IP3 receptors. IP3R1-3; tetrameric calcium channels on the ER.
  • PKC isoforms. Conventional, novel, and atypical families.
  • Calcium. Central downstream messenger; see calcium signaling.
  • DAG kinases and lipid phosphatases. Terminate DAG signaling.

Clinical Relevance / Therapeutic Targeting

The IP3-DAG pathway drives smooth muscle contraction in asthma, hypertension, and irritable bowel disease; glandular secretion; platelet aggregation; and immune cell activation. Many therapies act at Gq-coupled receptors upstream of the pathway: angiotensin II receptor blockers (AT1 is Gq-coupled), endothelin receptor antagonists, and H1 antihistamines. PKC inhibitors are explored for diabetic complications and oncology. Genetic diseases of IP3 receptors and PLC isoforms cause cerebellar ataxias, bleeding disorders, and immunodeficiencies.

Peptides That Target This Pathway

  • Oxytocin — Gq-coupled receptor drives uterine contraction via IP3/calcium.
  • Angiotensin II — AT1 receptor activates PLC-beta.
  • Vasopressin — V1 receptor engages Gq; V2 uses Gs for cAMP.
  • Bradykinin — B2 receptor couples to Gq and PLC.
  • GnRH — Gq-coupled receptor drives pituitary gonadotropin secretion.
  • Substance P — NK1 receptor activates PLC signaling.

Related entries

  • Calcium Signaling— Calcium signaling is a universal intracellular communication system in which transient rises in cytoplasmic calcium concentration trigger diverse cellular responses including muscle contraction, neurotransmitter release, gene expression, and hormone secretion.
  • Calcium Signaling— The use of calcium ion gradients as a universal intracellular second messenger controlling contraction, secretion, gene expression, and apoptosis.
  • cAMP Signaling— The signaling pathway built around cyclic AMP, a second messenger generated by adenylyl cyclase that regulates diverse physiological processes through PKA and Epac.
  • GPCR Signaling Basics— Introduction to how G protein-coupled receptors detect extracellular signals and convert them into intracellular responses through heterotrimeric G proteins.
  • Second Messenger Systems— Small intracellular molecules that relay and amplify signals from receptors to downstream effectors, including cAMP, cGMP, IP3, DAG, and calcium.